Alkermes plc - Ordinary Shares — Quarterly Cash Flow (NASDAQ:ALKS) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 2.08 B2.25 B2.33 B2.49 B4.26 B Total liabilities 570.39 M628.23 M596.08 M667.7 M2.51 B Total equity 1.51 B1.62 B1.73 B1.82 B1.75 B Total liabilities & shareholders' equities 2.08 B2.25 B2.33 B2.49 B4.26 B Total debt ————1.48 B Net debt ————1.48 B

News

Arcturus Therapeutics (ARCT) Stock Jumps 5.7%: Will It Continue to Soar?

Is HRMY Stock Worth Buying With Neutral Signals and Cheap Valuation?

HRMY Growth Trends Beyond Wakix Could Shape Its Next Growth Phase

Alkermes: "Buy" On Avadel Acquisition And Positive NT2 Data With Alixorexton (NASDAQ:ALKS)

ALKS' Sleep Disorder Drug Gets Orphan Drug Tags in the U.S. & Europe

Alkermes plc (ALKS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Why Is Revolution Medicines (RVMD) Up 9.3% Since Last Earnings Report?

Alkermes (ALKS) Up 21.1% Since Last Earnings Report: Can It Continue?

Alkermes Analysts Increase Their Forecasts Following Strong Q1 Results - Alkermes (NASDAQ:ALKS)

Alkermes' Q1 Earnings & Revenues Beat Estimates, Stock Rises

Alkermes: A Sleep Medicine Platform Hidden Inside A Mature CNS Company (ALKS)

Alkermes (ALKS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates